Deng YM

No ORCID on file · 1 paper in corpus
meta-analysis 2024
Endocrine ·doi:10.1007/s12020-023-03618-x

AIM: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) can improve long-term cardio-renal outcomes in patients with diabetes, heart failure (HF), or renal failure. We aimed to investigate the association of SGLT2is with the risks of vario…